Rxo (RXO) Net Cash Flow (2021 - 2026)

Rxo (RXO) has reported Net Cash Flow for 6 consecutive years, with $4.0 million the latest figure, recorded in Q1 2026.

• Net Cash Flow for Q1 2026 came in at $4.0 million, up 120.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.0 million (down 50.0% YoY), and the FY2025 annual result was -$19.0 million, down 159.38% from the prior year.
• Net Cash Flow was $4.0 million for Q1 2026 at Rxo, up from -$8.0 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $166.0 million in Q2 2022 and troughed at -$100.0 million in Q4 2023.
• Average Net Cash Flow over 5 years is -$375000.0, with a median of $2.0 million recorded in 2024.
• Year-over-year, Net Cash Flow slumped 8600.0% in 2022 and surged 352.63% in 2024.
• Over 5 years, Net Cash Flow stood at -$87.0 million in 2022, then slipped by 14.94% to -$100.0 million in 2023, then jumped by 82.0% to -$18.0 million in 2024, then surged by 55.56% to -$8.0 million in 2025, then soared by 150.0% to $4.0 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $4.0 million in Q1 2026, -$8.0 million in Q4 2025, and $7.0 million in Q3 2025.